Companies
Zimmer Biomet
S&P 500Health Care· USA

ZBH

Challenger

Zimmer Biomet

$95.34

+2.35%

Open $92.53·Prev $93.15

as of 13 Apr

CHALLENGER

Power Core

Power Core in one sentence: Zimmer Biomet's moat is the deep institutional entrenchment of its implant systems within hospital surgical programs, sustained by surgeon training relationships and a broad product portfolio that creates switching costs at the procedural level.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral Trajectory With Conditional Upward Optionality

ROC 200

-1.4%

Financials

Loading...

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
ZBH — Zimmer Biomet — Power Mapping Analysis — L17X — L17X